|
Ipca Laboratories Ltd [26-Jun-2026]
|
| Remarks : Krebs Biochemicals & Industries Ltd. |
|
| This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. (Transferor Company) with the Company (Ipca Laboratories Ltd.) (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. |
|
Krebs Biochemicals & Industries Ltd [26-Jun-2026]
|
| Remarks : Krebs Biochemicals & Industries Ltd. |
|
| This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. (Transferor Company) with the Company (Ipca Laboratories Ltd.) (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. |
|
Kisan Mouldings Ltd [26-Jun-2026]
|
| Remarks : KML Tradelinks Pvt Ltd. |
|
| SCRIP Code: 531761
NSE Symbol: APOLLOPIPE
Outcome of Board Meeting |
|
Kisan Mouldings Ltd [26-Jun-2026]
|
| Remarks : Kisan Mouldings Ltd. |
|
| SCRIP Code: 531761 NSE Symbol: APOLLOPIPE Outcome of Board Meeting. |
|
Apollo Pipes Ltd [26-Jun-2026]
|
| Remarks : KML Tradelinks Pvt Ltd. |
|
| Outcome of Board Meeting. |
|
Apollo Pipes Ltd [26-Jun-2026]
|
| Remarks : Kisan Mouldings Ltd. |
|
| Outcome of Board Meeting |
|
Astral Ltd [25-Jun-2026]
|
| Remarks : Al-Aziz Plastics Pvt. Ltd. |
|
| Amalgamation of Al-Aziz Plastics Private Limited (the Transferor Company) into and with Astral Limited (the Transferee Company) and subsequent dissolution of the Transferor Company in the manner as set out in this Scheme; |
|
RPSG Ventures Ltd [25-Jun-2026]
|
| Remarks : Woodlands Multispeciality Hospital Ltd |
|
| A composite scheme of arrangement amongst the Company, Woodlands Multispeciality Hospital Limited ('WMHL') and Clarionix Healthcare Private Limited ('RPSG WOS') and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ('Act') ('Scheme'), which inter alia, provides for: (i) amalgamation of WMHL with the Company; and (ii) transfer and vesting of the Hospital & Nursing Undertaking (as defined in the Scheme) from the Company into RPSG WOS on a slump sale basis |
|
Woodlands Multispeciality Hospital Ltd [25-Jun-2026]
|
| Remarks : Woodlands Multispeciality Hospital Ltd |
|
| A composite scheme of arrangement amongst the Company, Woodlands Multispeciality Hospital Limited ('WMHL') and Clarionix Healthcare Private Limited ('RPSG WOS') and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ('Act') ('Scheme'), which inter alia, provides for: (i) amalgamation of WMHL with the Company; and (ii) transfer and vesting of the Hospital & Nursing Undertaking (as defined in the Scheme) from the Company into RPSG WOS on a slump sale basis |
|
Astral Coatings Pvt Ltd [25-Jun-2026]
|
| Remarks : Astral Ltd. |
|
| Demerger and Transfer of the Chemicals Business Undertaking along-with all its related assets and liabilities of Astral Limited (the Demerged Company) and vesting of the same with and into Astral Chemie Limited (formerly known as Astral Coatings Private Limited) (the Resulting Company), on a going concern basis in the manner as set out in this Scheme; |